Wednesday, October 8, 2025

Latest

Pure Extracts Outlines Psilocybin Study Timeline

Further details were released by Pure Extracts (CSE: PULL) this morning in relation to its study on the formulation and manufacturing of psilocybin-based active treatments for oral tablets, capsules and nasal gel. The company has now released the timetable as well as outlined the milestones for the study, which is expected to result in an investigational product.

News of the study was previously released by the company, with research to be conducted by company advisor Dr Alexander MacGregor at the Toronto Institute of Pharmaceutical Technology. The study itself is to focus on testing the rapid onset of psilocybin dosage forms that can be used for future efficacy trials, by both Pure and its customers.

It appears the entire product chain is to be included in the study, from formulating and manufacturing, to packaging and labelling. Also included is conformity and stability testing. Based on a 250-day timeline, the company has outlined the following key milestones:

  • Sourcing and procurement of medicinal ingredients, excipients & packaging materials
  • Raw Material Testing
  • Formulation and Manufacturing Process Development, Stability Testing
  • Clinical Batch Manufacturing
  • Quality Control Release Testing
  • Shipping of Clinical Batches to CRO

“We are excited about the R&D progress we are going to make with TIPT over the next 6 – 8 months while waiting to receive our Dealer’s License from Health Canada. We will be well prepared for our move into the controlled substances world of psychedelics and will have advanced knowledge regarding psilocybin and its associated novel delivery mechanisms.”

Ben Nikolaevsky, Pure Extracts CEO

Pure Extracts last traded at $0.62 on the CSE.


FULL DISCLOSURE: Pure Extracts is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pure Extracts on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Pure Extracts Raises $8.5 Million In Upsized Special Warrant Financing

Pure Extracts (CSE: PULL) yesterday announced the closure of its offering of special warrants, raising...

Friday, January 22, 2021, 11:03:00 AM

Pure Extracts Receives Health Canada Processing License

Pure Extracts (CSE: PULL, listing pending) has seen Health Canada grant the firm its standard...

Thursday, October 1, 2020, 10:13:00 AM

The Deep Dive Compiles Company Profile On Pure Extracts

Pure Extracts (CSE: PULL, tentatively) is positioned for growth in the commercial cannabis and functional mushroom...

Sunday, October 18, 2020, 10:49:00 AM

Pure Extracts To Begin Trading November 5, 2020

Pure Extracts Technologies (CSE: PULL) is set to finally begin trading this Thursday after months...

Tuesday, November 3, 2020, 03:01:00 PM

Pure Extracts: The Second Wave of Psychedelic Operators

Some years ago when the first wave of cannabis firms went public, operators were focused...

Saturday, June 13, 2020, 08:30:00 AM